Senate Democrats Unveil Standalone Health Legislation Following December Spending Bill Omissions
March 7, 2025 - 05:55
Senate Democrats are set to introduce a comprehensive package of health policies as standalone legislation, which includes significant reforms targeting the pharmacy benefit manager (PBM) industry. This move comes after key health provisions were excluded from the December government spending bill, prompting lawmakers to seek alternative pathways to advance their healthcare agenda.
The proposed legislation aims to enhance transparency and accountability within the PBM sector, which plays a crucial role in managing prescription drug benefits for millions of Americans. By implementing these changes, Democrats hope to lower prescription drug costs and improve access to necessary medications for patients across the country.
In addition to PBM reforms, the new package may address various other health-related issues, reflecting the party's commitment to bolstering healthcare access and affordability. As the legislative session progresses, the introduction of this standalone bill underscores the Democrats' determination to prioritize health policy reforms, despite previous setbacks in broader spending negotiations.
MORE NEWS
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...